1,2,4-triazole has been researched along with combretastatin in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (66.67) | 24.3611 |
| 2020's | 1 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Diao, PC; Li, Q; Li, YH; Yang, HK; You, WW; Zhang, B; Zhao, PL | 1 |
| Abdelhafez, EMN; Abdelhamid, D; Aly, OM; Gamal-Eldeen, AM; Ibrahim, MAA; Mustafa, M | 1 |
| Abdelhafeez, DA; Aly, OM; Mustafa, M; Nofal, AE; Shatla, IM | 1 |
3 other study(ies) available for 1,2,4-triazole and combretastatin
| Article | Year |
|---|---|
Design, synthesis, and biological evaluation of novel alkylsulfanyl-1,2,4-triazoles as cis-restricted combretastatin A-4 analogues.
Topics: Antineoplastic Agents; Bibenzyls; Cell Cycle Checkpoints; Cell Line, Tumor; Cell Proliferation; Drug Screening Assays, Antitumor; Humans; Neoplasms; Stereoisomerism; Structure-Activity Relationship; Triazoles | 2017 |
Synthesis, antiproliferative, anti-tubulin activity, and docking study of new 1,2,4-triazoles as potential combretastatin analogues.
Topics: Antineoplastic Agents; Bibenzyls; Cell Proliferation; Dose-Response Relationship, Drug; Drug Screening Assays, Antitumor; Humans; Molecular Docking Simulation; Molecular Structure; Polymerization; Structure-Activity Relationship; Triazoles; Tubulin; Tubulin Modulators; Tumor Cells, Cultured | 2017 |
OMA1520 and OMA1774, novel 1,2,4-triazole bearing analogs of combretastatin A-4, inhibit hepatocellular carcinoma: Histological and immunohistochemical studies.
Topics: Animals; Antineoplastic Agents, Phytogenic; Bibenzyls; Carcinoma, Hepatocellular; Hep G2 Cells; HL-60 Cells; Humans; Liver Neoplasms, Experimental; Male; MCF-7 Cells; Molecular Docking Simulation; Rats; Triazoles | 2021 |